This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Gabapentin Augmentation for Fluoxetine-Treated Patients With Obsessive-Compulsive Disorder

Gabriela Corá-Locatelli, Benjamin D. Greenberg, Juliet Martin, and Dennis L. Murphy

Published: September 15, 1998

Article Abstract

Sir: Serotonin reuptake inhibitors (SRIs) are the most effective pharmacologic treatment for obsessive-compulsive disorder (OCD). However, few patients have a complete response to SRIs. Because augmentation strategies are needed, we initiated a pilot study of gabapentin in patients with OCD who had a partial or incomplete response to SRI treatment.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 59

Quick Links: